Published in Acta Biomater on March 18, 2010
The future of biologic coatings for orthopaedic implants. Biomaterials (2013) 1.53
Scaffold translation: barriers between concept and clinic. Tissue Eng Part B Rev (2011) 1.25
Controllable mineral coatings on PCL scaffolds as carriers for growth factor release. Biomaterials (2011) 1.17
Mineral coatings for temporally controlled delivery of multiple proteins. Adv Mater (2011) 1.06
Biomimetic CaP coating incorporated with parathyroid hormone improves the osseointegration of titanium implant. J Mater Sci Mater Med (2012) 0.87
Functionalizing calcium phosphate biomaterials with antibacterial silver particles. Adv Mater (2012) 0.84
New Ti-Alloys and Surface Modifications to Improve the Mechanical Properties and the Biological Response to Orthopedic and Dental Implants: A Review. Biomed Res Int (2016) 0.83
Chemical and physical properties of carbonated hydroxyapatite affect breast cancer cell behavior. Acta Biomater (2015) 0.83
Regenerated silk materials for functionalized silk orthopedic devices by mimicking natural processing. Biomaterials (2016) 0.80
Tailoring biomaterial surface properties to modulate host-implant interactions: implication in cardiovascular and bone therapy. J Mater Chem B Mater Biol Med (2015) 0.78
Sonoporation increases therapeutic efficacy of inducible and constitutive BMP2/7 in vivo gene delivery. Hum Gene Ther Methods (2013) 0.78
3-D Scaffold Platform for Optimized Non-viral Transfection of Multipotent Stem Cells. J Mater Chem B Mater Biol Med (2014) 0.76
Effects of BMP-12-releasing sutures on Achilles tendon healing. Tissue Eng Part A (2014) 0.75
Rapid purification of plasmid DNAs by hydroxyapatite chromatography. Eur J Biochem (1978) 12.63
Transfecting mammalian cells: optimization of critical parameters affecting calcium-phosphate precipitate formation. Nucleic Acids Res (1996) 4.79
DNA delivery from polymer matrices for tissue engineering. Nat Biotechnol (1999) 3.37
Ca,P-rich layer formed on high-strength bioactive glass-ceramic A-W. J Biomed Mater Res (1990) 2.22
Calcium orthophosphates: crystallization and dissolution. Chem Rev (2008) 1.67
Hydroxyapatite particles as a controlled release carrier of protein. Biomaterials (2004) 1.57
Surface-mediated gene transfer from nanocomposites of controlled texture. Nat Mater (2004) 1.45
The effect of biomimetic apatite structure on osteoblast viability, proliferation, and gene expression. Biomaterials (2005) 1.43
Bone regeneration: molecular and cellular interactions with calcium phosphate ceramics. Int J Nanomedicine (2006) 1.40
Theoretical analysis of calcium phosphate precipitation in simulated body fluid. Biomaterials (2005) 1.40
Growth of continuous bonelike mineral within porous poly(lactide-co-glycolide) scaffolds in vitro. J Biomed Mater Res (2000) 1.35
Review: mineralization of synthetic polymer scaffolds for bone tissue engineering. Tissue Eng (2007) 1.35
Preparation of SBF with different HCO3- content and its influence on the composition of biomimetic apatites. Acta Biomater (2006) 1.34
The role of brushite and octacalcium phosphate in apatite formation. Crit Rev Oral Biol Med (1992) 1.21
Surface adsorption of DNA to tissue engineering scaffolds for efficient gene delivery. J Biomed Mater Res A (2006) 1.20
A comparative study of calcium phosphate formation on bioceramics in vitro and in vivo. Biomaterials (2005) 1.17
TEM-EDX study of mechanism of bonelike apatite formation on bioactive titanium metal in simulated body fluid. J Biomed Mater Res (2001) 1.16
Sustained delivery of plasmid DNA from polymeric scaffolds for tissue engineering. Adv Drug Deliv Rev (2006) 1.13
A comparative study between in vivo bone ingrowth and in vitro apatite formation on Na2O-CaO-SiO2 glasses. Biomaterials (2003) 1.13
Effects of hydroxylapatite coating crystallinity on biosolubility, cell attachment efficiency and proliferation in vitro. Biomaterials (1999) 1.12
The effect of pH on the structural evolution of accelerated biomimetic apatite. Biomaterials (2004) 1.01
Nucleation of biomimetic Ca-P coatings on ti6A14V from a SBF x 5 solution: influence of magnesium. Biomaterials (2002) 1.01
Biomimetic coatings on titanium: a crystal growth study of octacalcium phosphate. J Mater Sci Mater Med (2001) 1.00
Significance of the porosity and physical chemistry of calcium phosphate ceramics. Biodegradation-bioresorption. Ann N Y Acad Sci (1988) 1.00
Dissolution and mineralization behaviors of HA coatings. Biomaterials (2003) 0.99
Apatite-coated poly(lactic-co-glycolic acid) microspheres as an injectable scaffold for bone tissue engineering. J Biomed Mater Res A (2008) 0.90
Biological calcium phosphates and their role in the physiology of bone and dental tissues I. Composition and solubility of calcium phosphates. Calcif Tissue Res (1978) 0.81
Comparison of different types of ceramic hydroxyapatite for the chromatographic separation of plasmid DNA and a recombinant anti-rhesus D antibody. Bioseparation (2000) 0.79
Mouse embryonic stem cell colonisation of carbonated apatite surfaces. Biomaterials (2005) 0.79
Biological implications of polydimethylsiloxane-based microfluidic cell culture. Lab Chip (2009) 2.59
Moving from static to dynamic complexity in hydrogel design. Nat Commun (2012) 1.40
An approach to modulate degradation and mesenchymal stem cell behavior in poly(ethylene glycol) networks. Biomacromolecules (2008) 1.34
Scaffold translation: barriers between concept and clinic. Tissue Eng Part B Rev (2011) 1.25
Modular peptides promote human mesenchymal stem cell differentiation on biomaterial surfaces. Acta Biomater (2009) 1.19
Controlled nucleation of hydroxyapatite on alginate scaffolds for stem cell-based bone tissue engineering. J Biomed Mater Res A (2010) 1.18
Controllable mineral coatings on PCL scaffolds as carriers for growth factor release. Biomaterials (2011) 1.17
Biomaterials that regulate growth factor activity via bioinspired interactions. Adv Funct Mater (2011) 1.16
Triggered drug release from dynamic microspheres via a protein conformational change. Macromol Biosci (2010) 1.16
Screening for 3D environments that support human mesenchymal stem cell viability using hydrogel arrays. Tissue Eng Part A (2009) 1.12
Harnessing endogenous growth factor activity modulates stem cell behavior. Integr Biol (Camb) (2011) 1.09
Mineral coatings for temporally controlled delivery of multiple proteins. Adv Mater (2011) 1.06
An adaptable hydrogel array format for 3-dimensional cell culture and analysis. Biomaterials (2008) 1.05
Using "click" chemistry to prepare SAM substrates to study stem cell adhesion. Langmuir (2009) 1.04
Modular peptide growth factors for substrate-mediated stem cell differentiation. Angew Chem Int Ed Engl (2009) 1.02
Specific VEGF sequestering and release using peptide-functionalized hydrogel microspheres. Biomaterials (2012) 1.02
Immobilization of peptides with distinct biological activities onto stem cell culture substrates using orthogonal chemistries. Langmuir (2010) 1.02
A modular, hydroxyapatite-binding version of vascular endothelial growth factor. Adv Mater (2010) 1.01
Influence of hydroxyapatite-coated and growth factor-releasing interference screws on tendon-bone healing in an ovine model. Arthroscopy (2009) 1.01
Surfaces that sequester serum-borne heparin amplify growth factor activity. Adv Mater (2011) 1.00
Patterning discrete stem cell culture environments via localized self-assembled monolayer replacement. Langmuir (2009) 0.99
Human vascular tissue models formed from human induced pluripotent stem cell derived endothelial cells. Stem Cell Rev (2015) 0.98
Extending foldamer design beyond α-helix mimicry: α/β-peptide inhibitors of vascular endothelial growth factor signaling. J Am Chem Soc (2012) 0.95
Retracted Immunoisolating pancreatic islets by encapsulation with selective withdrawal. Small (2007) 0.94
Growth of hydroxyapatite coatings on biodegradable polymer microspheres. ACS Appl Mater Interfaces (2009) 0.94
Substrates for cell adhesion prepared via active site-directed immobilization of a protein domain. Langmuir (2004) 0.93
Differential effects of a soluble or immobilized VEGFR-binding peptide. Integr Biol (Camb) (2012) 0.93
Coating with a modular bone morphogenetic peptide promotes healing of a bone-implant gap in an ovine model. PLoS One (2012) 0.91
Interleukin expression after injury and the effects of interleukin-1 receptor antagonist. PLoS One (2013) 0.90
Influence of FGF2 and PEG hydrogel matrix properties on hMSC viability and spreading. J Biomed Mater Res A (2010) 0.89
Mineral coatings modulate β-TCP stability and enable growth factor binding and release. Acta Biomater (2011) 0.88
Patterned self-assembled monolayers: efficient, chemically defined tools for cell biology. Chembiochem (2012) 0.88
Interleukin-1 receptor antagonist modulates inflammation and scarring after ligament injury. Connect Tissue Res (2014) 0.87
Inorganic coatings for optimized non-viral transfection of stem cells. Sci Rep (2013) 0.87
A chemically-defined screening platform reveals behavioral similarities between primary human mesenchymal stem cells and endothelial cells. Integr Biol (Camb) (2012) 0.87
Design of growth factor sequestering biomaterials. Chem Commun (Camb) (2014) 0.87
Facile formation of dynamic hydrogel microspheres for triggered growth factor delivery. Acta Biomater (2010) 0.86
Hydrogels with well-defined peptide-hydrogel spacing and concentration: impact on epithelial cell behavior(). Soft Matter (2011) 0.85
Controllable Soluble Protein Concentration Gradients in Hydrogel Networks. Adv Funct Mater (2008) 0.85
High affinity binding of an engineered, modular peptide to bone tissue. Mol Pharm (2013) 0.84
Regulating specific growth factor signaling using immobilized branched ligands. Adv Healthc Mater (2012) 0.84
Screening the cellular microenvironment: a role for microfluidics. IEEE Rev Biomed Eng (2008) 0.84
Functionalizing calcium phosphate biomaterials with antibacterial silver particles. Adv Mater (2012) 0.84
Biomimetic approaches to control soluble concentration gradients in biomaterials. Macromol Biosci (2011) 0.83
Biomineral coating increases bone formation by ex vivo BMP-7 gene therapy in rapid prototyped poly(L-lactic acid) (PLLA) and poly(ε-caprolactone) (PCL) porous scaffolds. Adv Healthc Mater (2014) 0.83
Multifunctional mixed SAMs that promote both cell adhesion and noncovalent DNA immobilization. Langmuir (2008) 0.82
Engineering the emergence of stem cell therapeutics. Sci Transl Med (2013) 0.81
Specific VEGF sequestering to biomaterials: influence of serum stability. Acta Biomater (2013) 0.81
Controlled multiple growth factor delivery from bone tissue engineering scaffolds via designed affinity. Tissue Eng Part A (2013) 0.81
Effects of pseudowollastonite (CaSiO3) bioceramic on in vitro activity of human mesenchymal stem cells. Biomaterials (2010) 0.81
Use of micro-computed tomography to nondestructively characterize biomineral coatings on solid freeform fabricated poly (L-lactic acid) and poly ((ε-caprolactone) scaffolds in vitro and in vivo. Tissue Eng Part C Methods (2013) 0.81
Combinatorial screening of chemically defined human mesenchymal stem cell culture substrates. J Mater Chem (2012) 0.81
Serum-dependence of affinity-mediated VEGF release from biomimetic microspheres. Biomacromolecules (2014) 0.80
Molecular-scale biomimicry. Nat Biotechnol (2002) 0.80
A screening approach reveals the influence of mineral coating morphology on human mesenchymal stem cell differentiation. Biotechnol J (2013) 0.80
Environmental parameters influence non-viral transfection of human mesenchymal stem cells for tissue engineering applications. Cell Tissue Res (2012) 0.80
Biomaterials for high-throughput stem cell culture. Curr Stem Cell Res Ther (2010) 0.79
A human pluripotent stem cell platform for assessing developmental neural toxicity screening. Stem Cell Res Ther (2013) 0.78
Poly(ethylene glycol) hydrogels with adaptable mechanical and degradation properties for use in biomedical applications. Macromol Biosci (2014) 0.77
α/β-Peptide Foldamers Targeting Intracellular Protein-Protein Interactions with Activity in Living Cells. J Am Chem Soc (2015) 0.77
Arrays of topographically and peptide-functionalized hydrogels for analysis of biomimetic extracellular matrix properties. J Vac Sci Technol B Nanotechnol Microelectron (2012) 0.77
A general route for the synthesis of functional, protein-based hydrogel microspheres using tailored protein charge. Chem Commun (Camb) (2010) 0.75
Tracking injectable microspheres in dynamic tissues with encapsulated superparamagnetic iron oxide nanoparticles. Macromol Biosci (2012) 0.75
Regulating VEGF signaling in platelet concentrates via specific VEGF sequestering. Biomater Sci (2016) 0.75
Effects of BMP-12-releasing sutures on Achilles tendon healing. Tissue Eng Part A (2014) 0.75
The Influence of Biomaterials on Cytokine Production in 3D Cultures. Biomacromolecules (2017) 0.75
Selective adipose tissue ablation by localized, sustained drug delivery. Plast Reconstr Surg (2003) 0.75